Cooley's 2023 Life Sciences M&A Year In Review: Potent Mix Of Creativity And Resilience Spurs Activity Heading Into 2024 - Corporate and Company Law
In a subdued year for global M&A, deal-making in the life sciences industry came in waves, with a busy fourth quarter generating cautious optimism heading into 2024.